SPL 0.00% 9.2¢ starpharma holdings limited

Expectations for September

  1. 12,931 Posts.
    lightbulb Created with Sketch. 1455
    Data on Phase 2 Dep Docetaxel and Dep Cabazitaxel human trials

    Completion of recruitment and treatment of Viraleze™ human trial

    Share price appreciation to reflect the above

    Announcement of replacement for CEO

    Announcement of retirement of Chairman

    Hopefully new submission to FDA for NDA of Vivagel

    Announcement of new partners for distribution of Vivagel_b with substantial up front licensing fees
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.